Citation Impact
Citing Papers
Nelfinavir, A Lead HIV Protease Inhibitor, Is a Broad-Spectrum, Anticancer Agent that Induces Endoplasmic Reticulum Stress, Autophagy, and Apoptosis In vitro and In vivo
2007
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Agonist induced homologous desensitization of mu-opioid receptors mediated by G protein-coupled receptor kinases is dependent on agonist efficacy.
1998
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Atp Binding Cassette Multidrug Transporters Limit the Anti-HIV Activity of Zidovudine and Indinavir in Infected Human Macrophages
2004
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Therapeutic potential of resveratrol: the in vivo evidence
2006 Standout
Pharmacologic Optimization of Protease Inhibitors and Nonnucleoside Reverse Transcriptase Inhibitors (POPIN)-A Randomized Controlled Trial of Therapeutic Drug Monitoring and Adherence Support
2006
Ferroptosis: Death by Lipid Peroxidation
2015 Standout
Hepatocellular carcinoma
2018 Standout
Atazanavir plus low-dose ritonavir in pregnancy: pharmacokinetics and placental transfer
2007
Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs
2004 Standout
The impact of quasispecies dynamics on the use of therapeutics
2012
Has the era of individualised medicine arrived for antifungals? A review of antifungal pharmacogenomics
2011
Targeting Ferroptosis to Iron Out Cancer
2019 Standout
Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the xc − cystine transporter: a new action for an old drug
2001
Current role of LC-MS in therapeutic drug monitoring
2007
High-resolution crystal structure of human protease-activated receptor 1
2012 StandoutNatureNobel
Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection
2020
Modulation of oxidative stress as an anticancer strategy
2013 Standout
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
2016 StandoutNobel
Waves of resistance: Staphylococcus aureus in the antibiotic era
2009 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Efavirenz in the therapy of HIV infection
2009
The Effect of Intrinsic Efficacy on Opioid Tolerance
1995
Mechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs
2005
Therapeutic Drug Monitoring in the Treatment of Tuberculosis: An Update
2014
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
2007 Standout
Targeting multidrug resistance in cancer
2006 Standout
Structure-based drug screening for G-protein-coupled receptors
2012 StandoutNobel
Clinical failures of appropriately-treated methicillin-resistant Staphylococcus aureus infections
2008
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
2012 Standout
Quantification of Human Opiate Receptor Concentration and Affinity Using High and Low Specific Activity [11C]Diprenorphine and Positron Emission Tomography
1991
Clinical Pharmacokinetics and Summary of Efficacy and Tolerability of Atazanavir
2005
A new era of GPCR structural and chemical biology
2012 StandoutNobel
Use of therapeutic drug monitoring in HIV disease
2008
Glucose-Neopentyl Glycol (GNG) amphiphiles for membrane protein study
2012 StandoutNobel
Influence of viral chronic hepatitis co-infection on plasma drug concentrations and liver transaminase elevations upon therapy switch in HIV-positive patients
2006
G‐protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal
2004 StandoutNobel
Oxidative Stress in Cancer
2020 Standout
Ferroptosis: process and function
2016 Standout
Crystal structure of the µ-opioid receptor bound to a morphinan antagonist
2012 StandoutNatureNobel
Pharmacokinetics of Oxicam Nonsteroidal Anti-Inflammatory Agents
1994
Cyclodextrin-based pharmaceutics: past, present and future
2004 Standout
Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities
2008 Standout
Targeting ferroptosis as a vulnerability in cancer
2022 Standout
Periodontal diseases
2005 Standout
The biopsychosocial approach to chronic pain: Scientific advances and future directions.
2007 Standout
The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection
2012
Structure of the δ-opioid receptor bound to naltrindole
2012 StandoutNatureNobel
Tenofovir-Associated Acute and Chronic Kidney Disease: A Case of Multiple Drug Interactions
2005
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Bioluminescent sensor proteins for point-of-care therapeutic drug monitoring
2014 StandoutNobel
Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis
2002
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report
2006 Standout
Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study
2015 Standout
Lopinavir/ritonavir exposure in treatment-naive HIV-infected children following twice or once daily administration
2006
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
2011 Standout
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
2020 Standout
Therapeutic drug monitoring of antiretrovirals for people with HIV
2009
Plasma Levels, Safety, and 60-Week Efficacy of a Once-Daily Double-Boosted Protease Inhibitor Regimen of Atazanavir, Saquinavir, and Ritonavir
2008
Influence of Mutagenesis and Viral Load on the Sustained Low-Level Replication of an RNA Virus
2011
Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
2008
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Computational design of environmental sensors for the potent opioid fentanyl
2017 StandoutNobel
Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of Americaa
2012 Standout
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Markers of gut dysfunction do not explain low rifampicin bioavailability in HIV-associated TB
2017 StandoutNobel
Increased Replicative Fitness Can Lead to Decreased Drug Sensitivity of Hepatitis C Virus
2014 StandoutNobel
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
DESENSITIZATION OF G PROTEIN–COUPLED RECEPTORS AND NEURONAL FUNCTIONS
2004 StandoutNobel
A Revolution in Biomedical Assessment: The Development of Salivary Diagnostics
2001
Viral Quasispecies Evolution
2012
Association of Saquinavir Plasma Concentrations with Side Effects but Not with Antiretroviral Outcome in Patients Infected with Protease Inhibitor-Susceptible Human Immunodeficiency Virus Type 1
2007
Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment
2017 StandoutNobel
Barrier-Independent, Fitness-Associated Differences in Sofosbuvir Efficacy against Hepatitis C Virus
2016 StandoutNobel
Pharmacogenetics of Anti-HIV Drugs
2007
Works of Michael Kurowski being referenced
Initiation of HAART in Drug-Naive HIV Type 1 Patients Prevents Viral Breakthrough for a Median Period of 35.5 Months in 60% of the Patients
2002
Atazanavir enhances saquinavir hard-gel concentrations in a ritonavir-boosted once-daily regimen
2004
Transsynovial kinetics of piroxicam in patients with rheumatoid arthritis
1988
Placental transfer and pharmacokinetics of lopinavir and other protease inhibitors in combination with nevirapine at delivery
2006
Pharmacokinetic and tolerability profile of twice‐daily saquinavir hard gelatin capsules and saquinavir soft gelatin capsules boosted with ritonavir in healthy volunteers
2003
Antiviral efficacy, tolerability and pharmacokinetics of efavirenz in an unselected cohort of HIV-infected children
2008
Therapeutic drug monitoring in HIV infection: current status and future directions
2002
Therapy Failure following Selection of Enfuvirtide‐Resistant HIV‐1 in Cerebrospinal Fluid
2010
Pharmacokinetics of Saquinavir, Atazanavir, and Ritonavir in a Twice-Daily Boosted Double-Protease Inhibitor Regimen
2007
Low‐dose ritonavir moderately enhances nelfinavir exposure
2002
Impact of amphotericin B on the cytochrome P450 system in HIV-infected patients.
2004
[3H]-etorphine and [3H]-diprenorphine receptor binding in vitro and in vivo: differential effect of Na+ and guanylyl imidodiphosphate
1982
Is Helicobacter pylori infection a risk or protective factor for mucosal lesions development in patients chronically treated with acetylsalicylic acid?
1997
Current Status and Future Prospects of Therapeutic Drug Monitoring and Applied Clinical Pharmacology in Antiretroviral Therapy
2005
Predictors of treatment failure during highly active antiretroviral therapy (racing trial).
2002
Therapeutic Drug Monitoring and Drug–Drug Interactions Involving Antiretroviral Drugs
2005
Use of Saliva Specimens for Monitoring Indinavir Therapy in Human Immunodeficiency Virus-Infected Patients
2000
Severe CNS side-effect and persistent high efavirenz plasma levels in a patient with HIV/HCV coinfection and liver cirrhosis
2004
[3H]Etorphine receptor binding in vivo. Small fractional occupancy elicits analgesia.
1982